Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-30

Clinical Trial Update: Impact of 60 Days Powdered Tart Cherry Supplementation on Metabolic Syndrome [NA]

View source ↗

Summary

A completed clinical trial evaluating whether 60 days of powdered tart cherry supplementation affects metabolic syndrome parameters.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 60 Days Powdered Tart Cherry Supplement (tart cherry powder supplement)

Snippet

Sponsor: Ohio University | Conditions: Metabolic Syndrome | NA | Status: COMPLETED